| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2021 | Feb 17, 2021 | Denali Therapeutics Inc. | 10% Owner | Sell | 15.0 | -2,216,798 | -18.02% | ✗ | $144.1M |
| Dec 11, 2020 | Dec 15, 2020 | Denali Therapeutics Inc. | 10% Owner | Sell | 26.3 | -64,624 | -0.51% | ✗ | $5.2M |
| Aug 12, 2020 | Aug 14, 2020 | Denali Therapeutics Inc. | 10% Owner | Sell | 15.0 | -1,443,247 | -10.24% | ✗ | $45.7M |
| Jun 26, 2020 | Jun 30, 2020 | Denali Therapeutics Inc. | 10% Owner | Sell | 16.3 | -250,000 | -1.74% | ✗ | $6M |
| Jun 19, 2020 | Jun 23, 2020 | Denali Therapeutics Inc. | 10% Owner | Sell | 16.3 | -255,000 | -1.75% | ✗ | $6.3M |
| Jun 5, 2020 | Jun 9, 2020 | Denali Therapeutics Inc. | 10% Owner | Sell | 15.0 | -1,922,855 | -11.64% | ✗ | $49.5M |
| Feb 26, 2020 | Feb 28, 2020 | Denali Therapeutics Inc. | 10% Owner | Sell | 15.0 | -3,894,764 | -19.08% | ✗ | $78.9M |
| Jul 24, 2018 | Jul 26, 2018 | Aquestive Therapeutics, Inc. | Director | Buy | 100.0 | +165,000 | 219.75% | ✗ | $2.5M |
| Dec 12, 2017 | Dec 14, 2017 | Denali Therapeutics Inc. | 10% Owner | Buy | 87.5 | +275,000 | 1.43% | ✗ | $5M |